Predicting chemotherapy response in pediatric lymphoma using pre-treatment contrast-enhanced CT radiomics: A hypothesis-generating study
Abdominal Radiology · 2025
DOI: 10.1007/s00261-025-05283-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Abdominal Radiology, 2025. Verfasst von Yingxue Tong und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Minis…. Hauptthemen laut MEDLINE: Contrast Media, Lymphoma, Tomography, X-Ray Computed, Radiographic Image Enhancement. Die Arbeit nennt 31 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
PURPOSE: To preliminarily evaluate the predictive value of baseline contrast-enhanced CT (CECT) radiomics for assessing chemotherapy response in pediatric lymphoma. METHODS: This retrospective study included 92 pediatric patients with lymphoma (72 males, 20 females). Patients were classified as responders (n = 74) and non-responders (n = 18) based on treatment outcomes. The cohort was randomly stratified into a training set (n = 65, 70%) and a test set (n = 27, 30%). A total of 960 radiomics features were extracted from venous-phase baseline CECT images of target lesions. Feature selection was performed, and a logistic regression model was developed for response classification using the Synthetic Minority Over-sampling Technique (SMOTE). To evaluate model robustness, the entire radiomics pipeline was repeated across 10 independent randomized train-test splits. Model performance was evaluated using receiver operating characteristic (ROC) curve analysis, reporting the area under the ROC curve (AUC), 95% confidence intervals (CIs), and accuracy. RESULTS: Eight radiomics features were selected for the final model, including four filter-transformed first-order features and four filter-transformed texture features. The SMOTE model achieved an AUC of 0.883 (95% CI: 0.799-0.967) and an accuracy of 0.800 in the training set. In the test set, the SMOTE model achieved an AUC of 0.809 (95% CI: 0.606-1.000) and an accuracy of 0.741. In repeated validation, the SMOTE model showed mean AUCs of 0.915 (training) and 0.767 (test) across 10 splits. CONCLUSION: This hypothesis-generating study demonstrates that baseline CECT radiomics shows promise for predicting chemotherapy response in pediatric lymphoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Ch…
ORCID-Profile: Haoru Wang, Jinhua Cai
Zitieren
APA
Tong, Y., Wang, H., Zhang, X., Sun, C., & Cai, J. (2025). Predicting chemotherapy response in pediatric lymphoma using pre-treatment contrast-enhanced CT radiomics: A hypothesis-generating study. Abdominal Radiology. https://doi.org/10.1007/s00261-025-05283-2
Vancouver
Tong Y, Wang H, Zhang X, Sun C, Cai J. Predicting chemotherapy response in pediatric lymphoma using pre-treatment contrast-enhanced CT radiomics: A hypothesis-generating study. Abdominal Radiology. 2025. doi:10.1007/s00261-025-05283-2
BibTeX
@article{Tong2025,
author = {Tong, Yingxue and Wang, Haoru and Zhang, Xiangmin and Sun, Chunlan and Cai, Jinhua},
title = {Predicting chemotherapy response in pediatric lymphoma using pre-treatment contrast-enhanced CT radiomics: A hypothesis-generating study},
journal = {Abdominal Radiology},
year = {2025},
doi = {10.1007/s00261-025-05283-2}
}
EUVIMED